Allspring Global Investments Holdings, LLC Iveric Bio, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023
SELL
$18.67 - $24.56 $36,443 - $47,941
-1,952 Reduced 36.99%
3,325 $80,000
Q4 2022

Jan 23, 2023
SELL
$17.24 - $23.95 $1,999 - $2,778
-116 Reduced 2.15%
5,277 $0
Q3 2022

Oct 26, 2022
SELL
$9.4 - $18.59 $42,036 - $83,134
-4,472 Reduced 45.33%
5,393 $96,000
Q2 2022

Jul 25, 2022
SELL
$9.12 - $18.9 $297,038 - $615,573
-32,570 Reduced 76.75%
9,865 $94,000
Q1 2022

May 02, 2022
BUY
$12.15 - $16.83 $74,455 - $103,134
6,128 Added 16.88%
42,435 $714,000
Q4 2021

Jan 28, 2022
BUY
$13.83 - $18.78 $502,125 - $681,845
36,307 New
36,307 $607,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email